Lilly CEO Ricks provides hints on how Trump will approach healthcare issues
Fierce Pharma
DECEMBER 11, 2024
Wed.Dec 11, 2024
122 
Leriglitazone meets endpoint in trial for cerebral adrenoleukodystrophy
PharmaTimes
DECEMBER 11, 2024
Promising results set stage for European marketing authorization
Join 8,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
With Biktarvy patent cliff ahead, Gilead lays out a plan to keep the HIV crown with 7 launches through 2033
Fierce Pharma
DECEMBER 11, 2024
Er-Kim and Ascendis’ endocrine therapy agreement extended in Eurasia
Pharmaceutical Technology
DECEMBER 11, 2024
Er-Kim has extended its exclusive agreement with Ascendis Pharma for endocrinology treatments across multiple countries in Eurasia.
AI Strategies for Sales Managers: How to Cut Down on Tedious Admin Work
Advertisement
What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.
SABCS: Under siege from competitors, Pfizer's Ibrance scores in double-positive breast cancer
Fierce Pharma
DECEMBER 11, 2024
Social Health Platform Pyx Health Unveils Condition Management Program
MedCity News
DECEMBER 11, 2024
Pyx Health’s new condition management program will support people with conditions like diabetes, hypertension and pregnancy. The post Social Health Platform Pyx Health Unveils Condition Management Program appeared first on MedCity News.
Sign up to get articles personalized to your interests!
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
More Trending
iOnctura achieves new clinical milestones in uveal melanoma therapy
PharmaTimes
DECEMBER 11, 2024
Successful phase 1 study highlights potential of roginolisib
The Impact of USP Chapter on Endotoxin Testing
PharmaTech
DECEMBER 11, 2024
Pharmaceutical Technology spoke with Nicola Reid, Associate Director Product Management, Endotoxin Products at Charles River Laboratories, to get her perspective on endotoxin testing and USPs new Chapter Bacterial Endotoxins Test Using Recombinant Reagents.
ASH 2024 discussions shine spotlight on advances in haemophilia treatments
Pharmaceutical Technology
DECEMBER 11, 2024
When a room of physicians at ASH 2024 was asked whether they had prescribed a gene therapy in a commercial context, only a handful said yes.
AbbVie Acquires Aliada Therapeutics, Gains Neuroscience Pipeline
PharmaTech
DECEMBER 11, 2024
AbbVie has completed its acquisition of Aliada Therapeutics which includes Aliadas disease-modifying therapy for Alzheimers disease.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Vifor Pharma offers £23m to NHS to resolve CMA investigation
Pharmaceutical Technology
DECEMBER 11, 2024
If accepted, Vifor Pharma's 23m offer will "claw back" money for the NHS and close the CMA's first-ever disparagement case.
MedCity Pivot: A Chat with Accolade’s Chief Health Officer
MedCity News
DECEMBER 11, 2024
Dr. Shantanu Nundy describes how care navigation company Accolade can help self-insured employers lower costs for providing health coverage to their employees. The post MedCity Pivot: A Chat with Accolade’s Chief Health Officer appeared first on MedCity News.
Relation-GSK to drive fibrotic and osteoarthritis developments
Pharmaceutical Technology
DECEMBER 11, 2024
Relation has announced two strategic collaborations with GSK, focusing on new therapeutics for fibrotic and osteoarthritis.
Federated Models Offer New Paradigm for Data Monetization in Healthcare
MedCity News
DECEMBER 11, 2024
A new report by datma explores how companies can use federated data models to scale RWD. The post Federated Models Offer New Paradigm for Data Monetization in Healthcare appeared first on MedCity News.
How to Prove Marketing Value: Demonstrate Content ROI and Contribution to Sales
Advertisement
Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten
ASH 2024: J&J’s Tecvayli shows promise in transplant-eligible NDMM patient
Pharmaceutical Technology
DECEMBER 11, 2024
The prevailing treatment paradigm for newly diagnosed multiple myeloma (NDMM) patients who have received autologous stem cell transplantation (SCT) primarily consists of chemotherapy or Johnson & Johnsons (J&J) Darzalex in combination with chemotherapy.
Lilly’s £279m bet aims to boost UK life sciences sector
Pharmaceutical Technology
DECEMBER 11, 2024
Lillys investment and the UK governments strategic support for life sciences and healthcare represent a pivotal moment for the industry.
Trade & Channel Strategies 2024: Protecting the Pharma Supply Chain
Pharmaceutical Commerce
DECEMBER 11, 2024
The seminar focuses on US supply chain resiliency, while remaining compliant and preserving patient access.
Better prevention and treatment options needed for genital herpes, WHO says
Pharmaceutical Technology
DECEMBER 11, 2024
Updated figures from the WHO show that more than one in five adults aged between 15 and 49 globally have the infection.
Trade & Channel Strategies 2024: Patient-Centric 3.0 — How Direct-to-Patient is the New Commercialization Model
Pharmaceutical Commerce
DECEMBER 11, 2024
Breakout session explores how direct-to-patient models shorten the time to diagnosis and therapy to improve patient outcomes.
Dr Myles Greenberg becomes president and CEO of InCarda Therapeutics
Pharmaceutical Technology
DECEMBER 11, 2024
InCarda Therapeutics has announced the appointment of Dr Myles Greenberg as its new president and chief executive officer (CEO).
Enhancing Quality Through Training
PharmaTech
DECEMBER 11, 2024
With so many personnel involved in the development and manufacture of pharmaceuticals, proper training of all staff is key to ensuring a quality product.
Increase Revenue With Better, Faster Sales Onboarding
Advertisement
Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.
How Pfizer management outplayed activist investor Starboard
Pharmaceutical Technology
DECEMBER 11, 2024
The push to replace Albert Bourla as Pfizers CEO drew attention from the pharma industry but was soon derailed by several events.
Survey: 85 percent of Life Science Professionals Concerned About Impact of differing AI Regulations on Cross-Border Collaboration
Copyright Clearance Center
DECEMBER 11, 2024
The post Survey: 85 percent of Life Science Professionals Concerned About Impact of differing AI Regulations on Cross-Border Collaboration appeared first on Copyright Clearance Center.
Mastering Your AI Budget for 2025 Success
PharmExec
DECEMBER 11, 2024
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
Overcoming the first hurdles: Navigating early phase challenges for biotechs
Pharmaceutical Technology
DECEMBER 11, 2024
Appropriately planning and conducting early phase clinical trials is critical to setting the stage for successful pivotal studies.
Trade & Channel Strategies 2024: Navigating Pharma and Its Distribution Models
Pharmaceutical Commerce
DECEMBER 11, 2024
A case study explores a way to potentially transform commercial organizations, while driving revenue growth.
The Innovations Shoring Up Clinical Supply Chain Integrity in the Age of Advanced Therapies
Pharmaceutical Technology
DECEMBER 11, 2024
Missing and incomplete data can cause headaches for clinical trial operators; new innovations are providing an antidote.
Novo Nordisk Gains Manufacturing Sites from Novo Holdings and Novavax while EC Approves Catalent Acquisition
PharmaTech
DECEMBER 11, 2024
The European Commission has approved Novo Holdings' acquisition of Catalent, which includes the related sale of three manufacturing sites to Novo Nordisk, which is also acquiring the Czech Republic manufacturing site of Novavax for $200 million.
Pharma Pulse 12/11/24: Building and Maintaining Relationships with High-Profile Clients, Nearly Half of Adults With Epilepsy Use CBD Products & more
Pharmaceutical Commerce
DECEMBER 11, 2024
The latest news for pharma industry insiders.
Using Generative AI in Sales: Pros, Cons, and Considerations According to Sellers
Advertisement
Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A
Let's personalize your content